24.47
price down icon2.20%   -0.55
after-market Handel nachbörslich: 24.70 0.23 +0.94%
loading
Schlusskurs vom Vortag:
$25.02
Offen:
$25.17
24-Stunden-Volumen:
2.30M
Relative Volume:
1.77
Marktkapitalisierung:
$1.92B
Einnahmen:
$399.58M
Nettoeinkommen (Verlust:
$-54.04M
KGV:
-32.63
EPS:
-0.75
Netto-Cashflow:
$40.13M
1W Leistung:
+4.08%
1M Leistung:
-10.63%
6M Leistung:
-44.94%
1J Leistung:
+6.25%
1-Tages-Spanne:
Value
$24.14
$25.19
1-Wochen-Bereich:
Value
$23.50
$26.11
52-Wochen-Spanne:
Value
$19.73
$47.32

Veracyte Inc Stock (VCYT) Company Profile

Name
Firmenname
Veracyte Inc
Name
Telefon
(650) 243-6300
Name
Adresse
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Name
Mitarbeiter
824
Name
Twitter
@veracyte
Name
Nächster Verdiensttermin
2025-02-24
Name
Neueste SEC-Einreichungen
Name
VCYT's Discussions on Twitter

Vergleichen Sie VCYT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
VCYT
Veracyte Inc
24.47 1.96B 399.58M -54.04M 40.13M -0.75
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
482.16 183.07B 43.21B 6.58B 6.17B 17.29
Diagnostics & Research icon
DHR
Danaher Corp
206.85 145.32B 24.01B 3.41B 4.86B 4.70
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
573.07 45.56B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
119.84 33.96B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
194.55 33.62B 15.50B 1.33B 2.16B 7.34

Veracyte Inc Stock (VCYT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-20 Eingeleitet Craig Hallum Buy
2024-12-05 Herabstufung Goldman Buy → Neutral
2024-11-15 Eingeleitet Wolfe Research Outperform
2024-10-16 Eingeleitet UBS Buy
2024-10-10 Eingeleitet Guggenheim Buy
2024-02-23 Bestätigt Needham Buy
2023-01-18 Herabstufung Raymond James Outperform → Mkt Perform
2023-01-05 Eingeleitet Scotiabank Sector Outperform
2022-01-07 Eingeleitet Stephens Overweight
2021-11-18 Fortgesetzt Goldman Buy
2021-06-15 Eingeleitet Raymond James Outperform
2021-02-18 Fortgesetzt Needham Buy
2021-01-28 Eingeleitet Truist Buy
2020-11-10 Eingeleitet KeyBanc Capital Markets Sector Weight
2020-09-09 Eingeleitet Morgan Stanley Underweight
2019-07-31 Eingeleitet Lake Street Buy
2019-07-02 Eingeleitet Needham Buy
2018-11-29 Herabstufung Janney Buy → Neutral
2018-10-31 Hochstufung Janney Neutral → Buy
2017-11-07 Herabstufung Janney Buy → Neutral
2017-11-07 Herabstufung Piper Jaffray Overweight → Neutral
2017-08-31 Fortgesetzt BTIG Research Buy
2016-11-14 Fortgesetzt Leerink Partners Outperform
2015-12-18 Eingeleitet Cantor Fitzgerald Buy
2015-06-11 Bestätigt Leerink Partners Outperform
2013-11-26 Eingeleitet William Blair Outperform
Alle ansehen

Veracyte Inc Aktie (VCYT) Neueste Nachrichten

pulisher
Jul 29, 2025

How institutional ownership impacts Veracyte Inc. stockShort-Term Swing Opportunity Summary Sheet - Newser

Jul 29, 2025
pulisher
Jul 28, 2025

Veracyte's S&P SmallCap 600 Inclusion: A Catalyst for Institutional Momentum and Long-Term Growth? - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

Veracyte's Index Inclusion: A Catalyst for Healthcare's Long-Term Resilience - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

Veracyte (VCYT) Soars 7% on S&P SmallCap 600 Inclusion - MSN

Jul 28, 2025
pulisher
Jul 28, 2025

Is it the right time to buy Veracyte Inc. stockAchieve rapid portfolio growth with expert guidance - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Veracyte (VCYT) Soars 7.0%: Is Further Upside Left in the Stock? - Yahoo Finance

Jul 28, 2025
pulisher
Jul 28, 2025

What are the technical indicators suggesting about Veracyte Inc.Free Wealth Planning Blueprint - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is Veracyte Inc. a Top Dividend Stock to Watch in 2025Top Gaining Low Risk Assets - metal.it

Jul 28, 2025
pulisher
Jul 27, 2025

What are analysts’ price targets for Veracyte Inc. in the next 12 monthsExceptional profit margins - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How strong is Veracyte Inc. company’s balance sheetDiscover dynamic stocks ready to soar - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Will Veracyte Inc. Stock Benefit from AI and Green Energy TrendsHigh Return Conservative Stocks - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

How does Veracyte Inc. generate profit in a changing economyRobust investment performance - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What is the risk reward ratio of investing in Veracyte Inc. stockBuild a balanced portfolio for long-term success - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What institutional investors are buying Veracyte Inc. stockInvest confidently with proven investment plans - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 26, 2025

Why Veracyte Inc. stock attracts strong analyst attentionFree Exclusive Group - Metal.it

Jul 26, 2025
pulisher
Jul 25, 2025

What analysts say about Veracyte Inc. stockUnprecedented growth rates - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Veracyte stock soars after S&P SmallCap 600 addition announcement By Investing.com - Investing.com Nigeria

Jul 25, 2025
pulisher
Jul 25, 2025

Veracyte stock soars after S&P SmallCap 600 addition announcement - Investing.com

Jul 25, 2025
pulisher
Jul 25, 2025

Veracyte Inc. Stock Analysis and ForecastDynamic profit opportunities - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Veracyte jumps after diagnostics company to join S&P 600 Small Cap Index - TradingView

Jul 25, 2025
pulisher
Jul 24, 2025

Veracyte Set to Join S&P SmallCap 600 | VCYT Stock News - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Veracyte's S&P SmallCap 600 Inclusion: A Catalyst for Small-Cap Healthcare Innovation - AInvest

Jul 24, 2025
pulisher
Jul 24, 2025

Veracyte Set to Join S&P SmallCap 600 - 富途牛牛

Jul 24, 2025
pulisher
Jul 24, 2025

Investors Don't See Light At End Of Veracyte, Inc.'s (NASDAQ:VCYT) Tunnel - 富途牛牛

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Veracyte Inc. stock pricePhenomenal investment performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Veracyte Inc. a good long term investmentHigh-yield capital appreciation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Published on: 2025-07-22 20:34:08 - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

CSBR names Veracyte exec Robert Brainin CEO; 700K option package | DNN SEC FilingForm 6-K - Stock Titan

Jul 21, 2025
pulisher
Jul 20, 2025

Are Veracyte, Inc.'s (NASDAQ:VCYT) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? - simplywall.st

Jul 20, 2025
pulisher
Jul 20, 2025

Principal Financial Group Inc. Raises Holdings in Veracyte, Inc. (NASDAQ:VCYT) - Defense World

Jul 20, 2025
pulisher
Jul 19, 2025

Should You Continue to Hold Veracyte Stock in Your Portfolio Now? - MSN

Jul 19, 2025

Finanzdaten der Veracyte Inc-Aktie (VCYT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research WAT
$303.19
price up icon 0.27%
$135.84
price down icon 1.57%
diagnostics_research DGX
$167.93
price up icon 0.05%
diagnostics_research LH
$261.72
price down icon 0.06%
diagnostics_research MTD
$1,266.10
price up icon 0.40%
diagnostics_research IQV
$194.55
price down icon 1.62%
Kapitalisierung:     |  Volumen (24h):